Compass Therapeutics (CMPX) Interest & Investment Income (2019 - 2026)
Compass Therapeutics (CMPX) reported Interest & Investment Income of -$439000.0 for Q1 2026, down 2095.0% on a YoY basis from $22005.0 in Q1 2025, and down 7416.67% sequentially from $6000.0 in Q4 2025.
Compass Therapeutics (CMPX) Interest & Investment Income (2019 - 2026) Analysis & Trends
Compass Therapeutics (CMPX) has 8 years of Interest & Investment Income data on file, last reported at -$439000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 2095.0% year-over-year to -$439000.0; the trailing twelve-month figure through Mar 2026 stood at -$349000.0 (down 224.64% YoY), and the FY2025 full-year result was $70000.0, down 59.54% from the prior year.
- Interest & Investment Income declined to -$439000.0 in Q1 2026, from $6000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $3.0 million in Q4 2022 to a low of -$512000.0 in Q2 2022.
- A 5-year average of $203437.5 and a median of $12000.0 in 2025 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income soared 62200.0% in 2022 and slumped 2095.0% in 2026, its largest moves.
- Tracing CMPX's Interest & Investment Income over 5 years: stood at $3.0 million in 2022, then sank by 84.44% to $467000.0 in 2023, then slumped by 159.1% to -$276000.0 in 2024, then surged by 102.17% to $6000.0 in 2025, then plunged by 7416.67% to -$439000.0 in 2026.
- Business Quant data shows CMPX's Interest & Investment Income at -$439000.0 in Q1 2026, $6000.0 in Q4 2025, and $66000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Compass Therapeutics | 393.30 Mn | 393.30 Mn | - | -439,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -439,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | 66,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Mar 31, 2025 | -20,000.00 |
| Dec 31, 2024 | -276,000.00 |
| Sep 30, 2024 | 577,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Mar 31, 2024 | -127,000.00 |
| Dec 31, 2023 | 467,000.00 |
| Sep 30, 2023 | 77,000.00 |
| Jun 30, 2023 | -361,000.00 |
| Mar 31, 2023 | 156,000.00 |
| Dec 31, 2022 | 3.00 Mn |
| Sep 30, 2022 | 623,000.00 |
| Jun 30, 2022 | -512,000.00 |
| Dec 31, 2021 | -25,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Mar 31, 2021 | 15,000.00 |
| Sep 30, 2020 | 70,000.00 |